Solitary fibrous tumor
Citation, DOI & article data
Solitary fibrous tumors are a rare neoplasm of mesenchymal origin that comprise less than 2% of all soft tissue tumors ranging from indolent tumors to more aggressive masses.
They can be very large and can occur essentially anywhere, although some areas are more characteristic than others. For a discussion of specific presentations of solitary fibrous tumors, please refer to:
- solitary fibrous tumors of the dura
- solitary fibrous tumors of the liver
- solitary fibrous tumor of the orbit
- solitary fibrous tumors of the pleura
- solitary fibrous tumor of the spinal cord
Solitary fibrous tumor is the preferred term replacing hemangiopericytoma in all regions 13.
Solitary fibrous tumors occur at essentially any age but are uncommon in childhood and somewhat more common in the 5th and 6th decades 13. Tumors of the pleura are reported in slightly older age groups 13 although this may be due to a combination of delayed presentation and the heterogeneity of published series.
The clinical presentation of solitary fibrous tumors is usually due to local mass effect and therefore will depend on the location and size of the tumor. Tumors in the head and neck tend, therefore, to present at a smaller size, whereas pleural and abdominal tumors later 13.
Rarely solitary fibrous tumors result in paraneoplastic non-islet cell tumor hypoglycemia (NICTH) known as Doege-Potter Syndrome which results from the secretion of insulin-like growth factor-2 (IGF-2) 4-7,11,13.
Rarer still is acromegaly 11.
Solitary fibrous tumors occur essentially anywhere, both within lined cavities (e.g. pleura, peritoneum, dura), solid organs (e.g. liver, spleen) and soft tissues (e.g. extremities, orbit, retroperitoneum). Some locations are more common than others 7,13:
- pleura (most common): ~30%
- meninges (intracranial and spinal cord 2-3): ~25%
- abdominal cavity and organs: ~20%
- trunk: ~10%
- extremities: ~10%
- head and neck: ~5%
Solitary fibrous tumors appear as sharply marginated multilobulated firm masses. The cut surface is dense and pale in color although areas of fat, hemorrhage, necrosis and myxomatous change can be encountered especially in higher-grade tumors. These more aggressive tumors may also demonstrate less well-defined margins with infiltration into adjacent tissues 13.
Solitary fibrous tumors have variable cellularity but generally are composed of a collagenous matrix with arrays of spindle cells. Areas of necrosis, cystic or myxoid change, calcification, hemorrhage, increased vascularity, atypia, or malignancy may also be seen 7-8. Blood vessels often contain large caliber thin-walled branching staghorn blood vessels 13.
More cellular tumors tend to represent higher grade lesions 13.
Solitary fibrous tumors, regardless of location, are characterized by the genomic inversion of 12q13 locus resulting in the fusion of NAB2 and STAT6 genes 13.
Immunohistochemical analysis can play an important role in the diagnosis and management. Solitary fibrous tumors are usually positive for the following markers 12,13:
- STAT6 nuclear staining as a surrogate marker of NAB2-STAT6 gene fusion (most sensitive and specific)
- CD34: a marker for normal endothelium and vascular tumors (~75% positive)
- BCL-2 (B-cell lymphoma 2 protein): a marker of terminal differentiation
- cytokeratin, S-100, and p53 proteins have shown increased expression in malignant solitary fibrous tumors
CT reveals a well-circumscribed, smooth, and lobulated soft tissue mass that may contain scattered calcifications. Smaller tumors tend to enhance homogeneously, whereas larger lesions may have central tubular or rounded low-attenuation areas due to cystic or necrotic change.
On MRI, benign solitary fibrous tumors usually have relatively homogeneous low-to-intermediate signal intensity relative to skeletal muscle on both T1-weighted imaging and T2-weighted imaging because of fibrous tissue, as well as intense enhancement.
In addition, there may be areas of subacute hemorrhage that have high T1-weighted signal intensity, as well as non-enhancing cystic or necrotic foci that are more heterogeneous and higher in T2-weighted signal intensity relative to the remainder of the tumor.
However, when a central focus of heterogeneity and variable contrast enhancement is identified in an SFT at CT or MRI, malignant degeneration should be considered 7.
Treatment and prognosis
Low grade solitary fibrous tumors tend to be smaller (<10 cm) in size and occur in younger individuals. They typically have a favorable outcome with surgical resection alone
In contrast, malignant/higher-grade tumors tend to be larger at the time of diagnosis (>10 cm), more commonly encountered in older individuals and have the expected histological features of malignancy (increased cellularity, increased mitotic activity, nuclear pleomorphism etc..) as well as necrosis and local infiltration 13. These have a poorer prognosis, especially if incompletely resected.
Optimal adjuvant therapy for this group is unknown, and close-interval follow-up is advised because there is an increased incidence of local recurrence.
Solitary fibrous tumors have a wide differential that largely depends on their location. For example, intracranial they very closely mimic meningiomas.
- 1. Vallat-decouvelaere AV, Dry SM, Fletcher CD. Atypical and malignant solitary fibrous tumors in extrathoracic locations: evidence of their comparability to intra-thoracic tumors. Am. J. Surg. Pathol. 1998;22 (12): 1501-11. Am. J. Surg. Pathol. (link) - Pubmed citation
- 2. Ogungbo B, Prakash S, Kulkarni G et-al. Cervical intra-/extramedullary solitary fibrous tumour. Br J Neurosurg. 2005;19 (3): 254-7. doi:10.1080/02688690500208528 - Pubmed citation
- 3. Metellus P, Bouvier C, Guyotat J et-al. Solitary fibrous tumors of the central nervous system: clinicopathological and therapeutic considerations of 18 cases. Neurosurgery. 2007;60 (4): 715-22. doi:10.1227/01.NEU.0000255418.93678.AD - Pubmed citation
- 4. Suter M, Gebhard S, Boumghar M et-al. Localized fibrous tumours of the pleura: 15 new cases and review of the literature. Eur J Cardiothorac Surg. 1998;14 (5): 453-9. Eur J Cardiothorac Surg (link) - Pubmed citation
- 5. Lee KS, Im JG, Choe KO et-al. CT findings in benign fibrous mesothelioma of the pleura: pathologic correlation in nine patients. AJR Am J Roentgenol. 1992;158 (5): 983-6. AJR Am J Roentgenol (abstract) - Pubmed citation
- 7. Haaga JR, Boll D. CT and MRI of the whole body. Mosby. (2009) ISBN:0323053750. Read it at Google Books - Find it at Amazon
- 8. Robbins SL, Kumar V, Abbas AK et-al. Robbins and Cotran Pathologic Basis of Disease. W.B. Saunders Company. (2010) ISBN:1416031219. Read it at Google Books - Find it at Amazon
- 9. Dähnert WF. Radiology Review Manual. Lippincott Williams & Wilkins. (2011) ISBN:1609139437. Read it at Google Books - Find it at Amazon
- 10. Gengler C, Guillou L. Solitary fibrous tumour and haemangiopericytoma: evolution of a concept. Histopathology. 2006;48 (1): 63-74. doi:10.1111/j.1365-2559.2005.02290.x - Pubmed citation
- 11. Khowaja A, Johnson-Rabbett B, Bantle J et-al. Hypoglycemia mediated by paraneoplastic production of Insulin like growth factor-2 from a malignant renal solitary fibrous tumor - clinical case and literature review. BMC Endocr Disord.14 (1): 49. doi:10.1186/1472-6823-14-49 - Free text at pubmed - Pubmed citation
- 12. Chick JF, Chauhan NR, Madan R. Solitary fibrous tumors of the thorax: nomenclature, epidemiology, radiologic and pathologic findings, differential diagnoses, and management. AJR. American journal of roentgenology. 200 (3): W238-48. doi:10.2214/AJR.11.8430 - Pubmed
- 13. Tariq M, Din N, Abdul-Ghafar J, Park Y. The Many Faces of Solitary Fibrous Tumor; Diversity of Histological Features, Differential Diagnosis and Role of Molecular Studies and Surrogate Markers in Avoiding Misdiagnosis and Predicting the Behavior. Diagn Pathol. 2021;16(1):32. doi:10.1186/s13000-021-01095-2 - Pubmed